Fiona Kuo

Fiona Kuo

Company: Arena Pharmaceuticals

Job title: Director, Clinical Science, Dermatology


Etrasimod: An Investigational Oral, Selective Sphingosine 1-Phosphate (S1P) Receptor Modulator for the Treatment of Atopic Dermatitis 12:00 pm

• Reviewing atopic dermatitis pathogenesis and current treatment landscape • Exploring the proposed mechanism of action of S1P receptor modulator and its role in inflammatory diseases including atopic dermatitis • Introducing etrasimod, an investigational, oral, selective S1P receptor modulator • Describing preclinical data of etrasimod in Th2 driven allergic contact dermatitis mouse model • Reviewing current…Read more

day: Day 1 AM - Track 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.